Organic & Biomolecular Chemistry
Paper
(8′-Amino-3′,6′-dioxaaminooctyl)-3α,7α,12α-trihydroxy- Procedure for HPTS fluorescent assay of metal ion transport
5β-cholan-24-amide. To a solution of N-[8′-(benzyloxycarbonyl- for boronocholates with and without fructose present
amino)-3′,6′-dioxaaminooctyl]-3α,7α,12α-trihydroxy-5β-cholan-
24-amide (0.2 g, 0.3 mmol) in methanol (10 mL) was added
A lipid thin film was first prepared by the addition of spectro-
scopic grade chloroform to egg yolk phosphatidylcholine
acetic acid (1.7 μL, 0.03 mmol) and 10% palladium on acti-
(EYPC, 40 mg, 52 μmol) and cholesterol (5 mg, 13 μmol) in a
vated charcoal (0.02 g). The reaction vessel was degassed three
round bottomed flask (5 mL). Chloroform was slowly evapor-
ated in vacuo at room temperature to leave a lipid thin film on
the interior of the flask. HPTS phosphate buffer (1.2 mL,
100 μM HPTS, 20 mM MnHmPO4, 100 mM MCl, pH 6.5 where
times and stirred under hydrogen overnight. The solution was
filtered over Celite and evaporated in vacuo before the addition
of dichloromethane (10 mL); the organic layer was washed suc-
cessively with saturated sodium hydrogen carbonate solution
M+ = Na+ or K+ as appropriate) was added, followed by detach-
(25 mL) and brine (25 mL). The organic layer was dried over
ment of the lipid film from the interior of the flask by vortex
magnesium sulphate, filtered, and the filtrate evaporated
agitation, and extruded through a polycarbonate membrane
in vacuo to yield the title compound as a pale yellow oil (0.16 g,
(200 nm pore size, 19×). To remove unencapsulated HPTS, an
1
99%). H-NMR (400 MHz, CD3OD, 25 °C): δH ppm 0.71 (3H, s,
aliquot of the suspension (1 mL) was diluted with phosphate
C18/19 CH3), 0.92 (3H, s, C18/19 CH3), 1.03 (3H, d, J = 6.5 Hz,
buffer (1.5 mL, pH 6.5) and purified by gel permeation
C21H3), 1.28–2.34 (24H, steroid CH/CH2), 3.15 (2H, t, J =
chromatography (GPC) on a PD10 desalting column (eluted
with 3.5 mL phosphate buffer). This provided a purified
suspension of HPTS-encapsulated vesicles (15.5 mM total lipid
concentration).
5.3 Hz, CH2NH2), 3.38 (2H, t, J = 4.7, NHCH2) 3.58 (2H, t, J =
5.9, NHCH2CH2), 3.69 (4H, s, OCH2CH2O), 3.73 (2H, t, J =
5.1 Hz, CH2CH2NH2), 3.82 (1H, m, C7H), 3.97 (1H, m, C12H).
13C-NMR (100 MHz, CD3OD, 25 °C): δC ppm 13.1, 17.9, 23.3,
An aliquot (25 μL) of the vesicle suspension was transferred
24.4, 28.0, 28.8, 29.7, 31.0, 31.3, 33.4, 34.2, 36.0, 36.6, 37.1,
to
a fluorescence cuvette containing phosphate buffer
40.3, 40.6, 40.8, 41.1, 43.2, 43.3, 47.6, 48.1, 68.0, 69.2, 70.8,
71.4, 71.5, 73.0, 74.2, 177.2. MS (ES+): m/z 539.5 [M + H]+.
HRMS for C30H54N2O6: expected 539.4015, found 539.4017.
(8′-((2-Boronobenzyl)amino)-3′,6′-dioxaaminooctyl)-3α,7α,12α-
trihydroxy-5β-cholan-24-amide (3). To a solution of (8′-amino-
3′,6′-dioxaaminooctyl)-3α,7α,12α-trihydroxy-5β-cholan-24-amide
(0.1 g, 0.19 mmol) in anhydrous methanol (5 mL) was added
2-formylphenylboronic acid (28 mg, 0.19 mmol) and stirred for
45 minutes. The reaction mixture was cooled to 0 °C and
sodium borohydride (36 mg, 0.95 mmol) was added slowly
portionwise, the resulting solution was stirred for 45 minutes
at 0 °C and for a further 3 hours at room temperature. The
solution was diluted with dichloromethane (20 mL) and
washed successively with dilute HCl (1 M, 5 mL), saturated
sodium hydrogen carbonate solution (5 mL) and brine (5 mL).
The organic layer was dried over magnesium sulphate, filtered
and the filtrate evaporated in vacuo to yield the title compound
(1.975 mL, 20 mM MnHnPO4, 100 mM MCl, pH 8.5 where M+ =
Na+ or K+ as appropriate) with stirring (0.19 mM total lipid
concentration) and fluorescence measurements were immedi-
ately started (ex. 405 nm and 460 nm, em. 510 nm, time inter-
val 8 s) as a function of time. After 180 s the relevant
ionophore was added (20 μL, 0.01 mM total ionophore concen-
tration, 5 mol%) and vesicles were lysed after 1200 s by the
addition of Triton X-100 (25 μL, 25% v/v in distilled water).
The change in the normalized ratio I460/I405 as a function of
time gave the rate of M+/OH− antiport across the phospholipid
bilayer. The above procedure was repeated at fructose concen-
trations of 0.25 mM, 0.5 mM, 10 mM, 0.1 M, 0.5 M, achieved
by ensuring each buffer composition contained the relevant
concentration of fructose.
U-tube metal picrate transport experiments
1
A chloroform solution of the potentially transporting species
(1 mM, 5 mL) was transferred to a glass U-tube (internal dia-
meter 10 mm) and incubated at 25 °C. To one side of the
U-tube was added a receiving phase of phosphate buffer
(2.5 mL, 20 mM NanHmPO4, 100 mM NaCl, pH 6.5), and to the
other side was added a source phase of 0.01% sodium picrate
in phosphate buffer (2.5 mL, 20 mM NanHmPO4, 100 mM
NaCl, pH 8.5). Addition of the source phase marked the start
of the experiment; aliquots (1 mL) were taken at intervals from
the receiving phase and analysed for the presence of picrate by
UV spectroscopy (356 nm); after each measurement the sample
was immediately replaced back in the receiving phase of the
U-tube. The chloroform was stirred (300 rpm) for the entire
experiment to aid diffusion through to the receiving phase.
3 as a white foam (116 mg, 91%). H-NMR (400 MHz, CD3OD,
25 °C): δH ppm 0.70 (3H, s, C18/19 CH3), 0.92 (3H, s, C18/19
CH3), 1.01 (3H, d, J = 6.7 Hz, C21H3), 1.05–2.35 (24 H steroid
CH/CH2), 3.09 (2H, t, J = 5.7 Hz, CH2NH), 3.29 (2H, t, J =
5.7 Hz, NHamideCH2), 3.36 (1H, m, C3H), 3.53 (2H, t, J = 5.1 Hz,
NHamideCH2CH2), 3.67 (4H, m, OCH2CH2O), 3.81 (3H, t, J =
5.4 Hz, CH2CH2NH + C7H), 3.95 (1H, m, C12H), 4.07 (2H, s,
PhCH2), 7.12–7.24 (3H, m, CHAr), 7.39–7.45 (1H, m, CHAr).
13C-NMR (100 MHz, CD3OD, 25 °C): δC ppm 13.1, 17.8, 23.2,
24.3, 27.9, 28.8, 29.6, 31.2, 33.3, 34.1, 35.9, 36.5, 37.0, 40.2,
40.5, 41.0, 43.0, 43.2, 48.1, 48.2, 49.1, 49.3, 54.9, 68.0, 69.0,
70.7, 71.2, 71.4, 72.9, 74.0, 79.5, 126.8, 127.7, 128.4, 128.9,
129.2, 131.5, 176.9. MS (ES+): m/z 637.5 (100%) [M − 2H2O +
H]+, 673.6 [M + H]+. HRMS for C37H57BN2O6: expected
637.4388,
found
637.4372.
Elemental
analysis
for
U-tube fructose transport experiments
C37H62BN2O9·CH2Cl2: expected C: 58.92%, H: 8.33%, N:
3.62%; found C: 58.46%, H: 8.19%, N: 3.41%. νmax/cm−1 3357 A chloroform solution of the potentially transporting species
(OH), 2930, 2869, 1649, 1214, 1076, 745.
(1 mM, 5 mL) was transferred to a glass U-tube (internal
This journal is © The Royal Society of Chemistry 2014
Org. Biomol. Chem., 2014, 12, 2576–2583 | 2581